1. Home
  2. GDOT vs AVXL Comparison

GDOT vs AVXL Comparison

Compare GDOT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$13.00

Market Cap

742.3M

Sector

Finance

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.68

Market Cap

635.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDOT
AVXL
Founded
1999
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
742.3M
635.6M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
GDOT
AVXL
Price
$13.00
$3.68
Analyst Decision
Sell
Strong Buy
Analyst Count
2
3
Target Price
$11.00
$22.00
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
11-10-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,007,128,000.00
N/A
Revenue This Year
$22.03
N/A
Revenue Next Year
$11.64
$141.92
P/E Ratio
N/A
N/A
Revenue Growth
23.16
N/A
52 Week Low
$6.13
$2.86
52 Week High
$15.41
$14.44

Technical Indicators

Market Signals
Indicator
GDOT
AVXL
Relative Strength Index (RSI) 65.39 28.04
Support Level $10.42 $3.00
Resistance Level $12.64 $4.05
Average True Range (ATR) 0.56 0.59
MACD 0.26 0.06
Stochastic Oscillator 98.29 18.11

Price Performance

Historical Comparison
GDOT
AVXL

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: